Skip to main content
SpringerLink
Log in

Non-invasive grading of primary brain tumours: Results of a comparative study between SPET with123I-α-methyl tyrosine and PET with18F-deoxyglucose

  • Original Article
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Use of iodine-123-α-methyl tyrosine (123I-IMT) allows investigation of the amino acid transport rate in gliomas. It was the aim of this study to compare the value of measurement of glucose metabolism with that of measurement of123I-IMT uptake for the non-invasive grading of brain tumours. The study population comprised 23 patients with histopathologically proven primary brain tumours; 14 had high-grade gliomas, and nine low-grade brain neoplasms. Glucose metabolism was studied using an ECAT EXACT 47 positron emission tomography (PET) camera and fluorine-18 fluorodeoxyglucose (18F-FDG);123I-IMT uptake was measured with the triple-headed single-photon emission tomography (SPET) camera, MULTISPECT 3.18F-FDG and123I-IMT uptake was quantified as ratios between the uptake by the tumour and contralateral regions of reference. Glucose metabolism and amino acid uptake of the brain tumours correlated significantly (r=0.71,P <0.001). Assuming discrimination thresholds between high-grade and low-grade tumours of 0.8 for18F-FDG uptake and 1.8 for123I-IMT uptake, the accuracy values of18F-FDG PET and123I-IMT SPET for differentiating between high-grade and low-grade tumours were 21/23 (91%) and 19/23 (83%), respectively. The difference in diagnostic performance was not significant on receiver operating characteristic analysis (P >0.4). It is concluded that there is no major difference between the PET investigation of glucose metabolism and the less expensive SPET measurement of amino acid uptake in terms of their accuracy in evaluating the malignancy grade of primary brain tumours. This encourages the performance of further studies to analyse the potential impact of123I-IMT SPET on the therapeutic management of patients with brain tumours.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schmidek HH. Surgical management of supratentorial gliomas. In: Schmidek HH, Sweet WH, eds.Operative neurosurgical techniques, 3rd edn. Philadelphia: Saunders; 1995: 517–534.

    Google Scholar 

  2. Glantz MJ, Burger PC, Herndon JE, Friedman AH, Cairncross JG, Vick NA, Schold SC. Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas.Neurology 1991; 41: 1741–1744.

    PubMed  Google Scholar 

  3. Di Chiro G. Positron emission tomography using [18F]fluorodeoxyglucose in brain tumours: a powerful diagnostic and prognostic tool.Invest Radiol 1986; 22: 360–371.

    Google Scholar 

  4. Patronas NJ, Di Chiro G, Kufta C, Bairamian D, Kornblith PL, Simon R, Larson SM. Prediction of survival in glioma patients by means of positron emission tomography.J Neurosurg 1985; 62: 816–822.

    PubMed  Google Scholar 

  5. Hölzer T, Herholz K, Jeske J, Heiss WD. FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma.J Comput Assist Tomogr 1993; 17: 681–687.

    PubMed  Google Scholar 

  6. Alavi JB, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M. Positron emission tomography in patients with glioma — a predictor of prognosis.Cancer 1988; 62: 1074–1078.

    PubMed  Google Scholar 

  7. Kim CK, Alavi JB, Alavi A, Reivich M. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose.J Neurooncol 1991; 10: 85–91.

    PubMed  Google Scholar 

  8. Mineura K, Sasajima T, Kowada M, Ogawa T, Hatazawa J, Shishido F, Uemura K. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas.Cancer 1994; 73: 2386–2394.

    PubMed  Google Scholar 

  9. Schifter T, Hoffman JM, Hanson MW, Boyko OB, Beam C, Paine S, Schold SC, Burger PC, Coleman RE. Serial FDG-PET studies in the prediction of survival in patients with primary brain tumours.J Comput Assist Tomogr 1993; 17: 509–516.

    PubMed  Google Scholar 

  10. Kuwert T, Morgenroth C, Woesler B, Matheja P, Palkovic S, Vollet B, Samnick S, Maasjosthusmann U, Lerch H, Gildehaus F-J, Wassmann H, Schober O. Uptake of iodine-123-α-methyl tyrosine by primary brain tumours and non-neoplastic brain lesions.Eur J Nucl Med 1996; 23: 1345–1353.

    PubMed  Google Scholar 

  11. Kleihues P, Burger PC, Scheithauer BW.Histological typing of tumours of the central nervous system. Berlin, Heidelberg, New York: Springer, 1993.

    Google Scholar 

  12. Kuwert T, Morgenroth C, Woesler B, Matheja P, Palkovic S, Vollet B, Schäfers M, Wassmann H, Schober O. Influence of size of regions of interest on the measurement of uptake of iodine-123-α-methyl tyrosine by brain tumours.Nucl Med Commun 1996; 17: 609–615.

    PubMed  Google Scholar 

  13. Machulla HJ, Skansdal A, Stöcklin G.123(125)Xe-exposed KIO3, a reagent for iodination with high specific activity.Radioclin Acta 1977; 24: 42–46.

    Google Scholar 

  14. Fischer S, Wolf H, Brandau W, Clausen M, Henze E, Schober O. Iodierung von α-Methyltyrosin (AMT): Optimierung der Methode für die Routinepräparationz.Nucl Med 1993; 32: A113.

    Google Scholar 

  15. Kuikka JT, Tenhunen-Eskelinen M, Jurvelin J, Kiliänen H. Physical performance of the Siemens Multi SPECT 3 gamma camera.Nucl Med Commun 1993; 14: 490–497.

    PubMed  Google Scholar 

  16. Chang LT. A method for attenuation correction in radionuclide computed tomography.IEEE Trans Nucl Sci 1978; NS-26/2: 2780–2789.

    Google Scholar 

  17. Wienhard K, Eriksson L, Grootoonk S, Casey M, Pietrzyk U, Heiss WD. Performance evaluation of the positron scanner ECAT EXACT.J Comput Assist Tomogr 1992; 16: 804–813.

    PubMed  Google Scholar 

  18. Talairach J, Tournoux P.Co-planar stereotactic atlas of the human brain. Stuttgart, New York: Thieme; 1988; 37–110.

    Google Scholar 

  19. Ogawa T, Kanno I, Shishido F, Inugami A, Higano S, Fujita H, Murakami M, Uemura K, Yasui N, Mineura K, Kowada M. Clinical value of PET with18F-fluorodeoxyglucose andl-methyl-11C-methionine for diagnosis of recurrent brain tumors and radiation injury.Acta Radiol 1991; 32: 197–202.

    PubMed  Google Scholar 

  20. Bortz J.Lehrbuch der Statistik, 2nd edn. Berlin, Heidelberg, New York: Springer, 1985.

    Google Scholar 

  21. Delbeke D, Meyerowitz C, Lapidus RL, Maciunas RJ, Jennings MT, Moots PL, Kessler RM. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.Radiology 1995; 195: 47–52.

    PubMed  Google Scholar 

  22. Metz CE. ROC methodology in radiologic imaging.Invest Radiol 1986; 21: 720–733.

    PubMed  Google Scholar 

  23. Metz CE. Quantification of failure to demonstrate statistical significance.Invest Radiol 1993; 28: 59–63.

    PubMed  Google Scholar 

  24. Müller SP, Reiners C. Untersuchungen und Empfehlungen zum Design von ROC-Studien in der Nuklearmedizin.Nucl Med 1995; 34: 24–31.

    Google Scholar 

  25. Herholz K, Friedrichs B, Jeske J, Heiss WD. Prognostic significance of positron emission tomography with F-18-fluorodeoxyglucose in gliomas.J Cancer Res Clin Oncol (Suppl) 1992; R119.

  26. Patronas NJ, Di Chiro G, Brooks RA, DeLaPaz RL, Kornblith PL, Smith BH, Rizzoli HV, Kessler RM, Manning RG, Channing M, Wolf AP, O'Connor CM. 18-Fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.Radiology 1982; 144: 885–889.

    PubMed  Google Scholar 

  27. Glantz MJ, Hoffman JM, Coleman RE, Friedman AH, Hanson MW, Burger PC, Herndon JE, Meisler WJ, Schold SC. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.Ann Neurol 1991; 29: 347–355.

    PubMed  Google Scholar 

  28. Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, Patronas NJ, Kufta CV, Kessler RM, Johnston GS, Manning RG, Wolf AP. Glucose utilization of cerebral gliomas measured by 18-F-fluorodeoxyglucose and positron emission tomography.Neurology 1982; 32: 1323–1329.

    PubMed  Google Scholar 

  29. Patronas NJ, Brooks RA, DeLaPaz RL, Smith BH, Kornblith PI, Di Chiro G. Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas.AJNR 1983; 4: 533–535.

    PubMed  Google Scholar 

  30. Derlon JM, Bourdet C, Bustany P; Chatel M, Theron J, Darcel F, Syrota A. [11C]l-methionine uptake in gliomas.Neursurgery 1989; 25: 720–728.

    Google Scholar 

  31. Wienhard K, Herholz K, Coenen HH, Rudolf J, Kling P, Stöcklin G, Heiss WD. Increased amino acid transport into brain tumors measured by PET ofl-(2-18F)fluorotyrosine.J Nucl Med 1991; 32: 1338–1346.

    PubMed  Google Scholar 

  32. Schober O, Meyer GJ, Stolke D, Hundeshagen H. Brain tumor imaging using C-11-labelledl-methionine andd-methionine.J Nucl Med 1985; 26: 98–99.

    PubMed  Google Scholar 

  33. Bergström M, Lundqvist H, Ericson K, Lilja A, Johnstrom P, Langstrom B, von Holst H, Eriksson L, Blomqvist G. Comparison of the accumulation kinetics ofl-(methyl-11C)-methionine andd-(methyl-11C)-methionine in brain tumors studied with positron emission tomography.Acta Radiol 1987; 28: 225–229.

    PubMed  Google Scholar 

  34. Ishiwata K, Kubota K, Murakami M, Kubota R, Sasaki T, Ishii S, Senda M. Re-evaluation of amino acid PET studies: Can the protein synthesis rates in brain and tumor tissues be measured in vivo?J Nucl Med 1993; 34: 1936–1943.

    PubMed  Google Scholar 

  35. Ogawa T, Shishido F, Kanno I, Inugami A, Fujita H, Murakami M, Shimosegawa E, Ito H, Hatazawa J, Okudera T, Uemura K, Yasui N, Mineura K. Cerebral glioma: evaluation with methionine PET.Radiology 1993; 186: 45–53.

    PubMed  Google Scholar 

  36. Ogawa T, Inugami A, Hatazawa J, Kanno I, Murakami M, Yasui N, Mineura K, Uemura K. Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F-18 andl-methyl-11C-methionine.AJNR 1996; 17: 345–353.

    PubMed  Google Scholar 

  37. Drane WE, Abbott FD, Nicole MW, Mastin ST, Kuperus JH. Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress.Radiology 1994; 191: 461–465.

    PubMed  Google Scholar 

  38. Langen KJ, Roosen N, Coenen HH, Kuikka JT, Kuwert T, Herzog H, Stöcklin G, Feinendegen LE. Brain and brain tumor uptake ofl-3-[123I]iodomethyl tyrosine: competition with naturall-amino acids.J Nucl Med 1991; 32 1225–1228.

    PubMed  Google Scholar 

  39. Langen KJ, Coenen HH, Roosen N, Kling P, Muzik O, Herzog H, Kuwert T, Stöcklin G, Feinendegen LE. SPECT studies of brain tumors withl-3-[123I]iodo-α-methyl tyrosine: comparison with PET,124IMT and first clinical results.J Nucl Med 1990; 31: 281–286.

    PubMed  Google Scholar 

  40. Kawai K, Fujibayashi Y, Saji H, Konishi J, Yokoyama A. New radioiodinated radiopharmaceutical for cerebral amino acid transport studies: 3-iodo-alpha-methyl-l-tyrosine [abstract].J Nucl Med 1988; 29: 778.

    Google Scholar 

  41. Guth-Tougelidis B, Müller S, Mehdorn MM, Knust EJ, Dutschka K, Reiners C.dl3-123I-iodo-α-methyltyrosine uptake in brain tumor recurrences.Nucl Med 1995; 34: 71–75.

    Google Scholar 

  42. Biersack HJ, Coenen HH, Stöcklin G, Reichmann K, Bockisch A, Oehr P, Kashab M, Rollmann O. Imaging of brain tumors withl-3-[123I]iodo-α-methyl tyrosine and SPECT.J Nucl Med 1989; 30: 110–112.

    PubMed  Google Scholar 

  43. Kuwert T, Sures T, Herzog H, Loken M, Hennerici M, Langen KJ, Feinendegen LE. On the influence of spatial resolution and of the size and form of regions of interest on the measurement of regional cerebral metabolic rates by positron emission tomography.J Neural Transm (Suppl) 1992; 37: 53–66.

    Google Scholar 

  44. Leskinen-Kallio S, Ruotsalainen U, Nagren K, Teräs M, Joensuu H. Uptake of caron-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study.J Nucl Med 1991; 32: 1211–1218.

    PubMed  Google Scholar 

  45. Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thallium-301 SPECT to quantitative malignancy grade of gliomas.J Neurosurg 1989; 71: 342–346.

    PubMed  Google Scholar 

  46. Oriuchi N, Tomiyoshi K, Inoue T, Ahmad K, Sarwar M, Tokunaga M, Suzuki H, Watanabe N, Hirano T, Horikoshi S, Shibasaki T, Tamura M, Endo K. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.J Nucl Med 1996; 37: 457–462.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Westfälische Wilhelms-Universität Münster, Germany

    Burkhard Woesler, Torsten Kuwert, Peter Matheja, Michael Schäfers, Bernhard Vollet, Klaus Schäfers, Hartmut Lerche, Wolfgang Brandau, Samuel Samnick, Hansdetlef Wassmann & Otmar Schober

  2. Department of Neurosurgery, Westfälische Wilhelms-Universität Münster, Germany

    Carlo Morgenroth & Stefan Palkovic

Authors
  1. Burkhard Woesler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Torsten Kuwert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carlo Morgenroth
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter Matheja
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stefan Palkovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michael Schäfers
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bernhard Vollet
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Klaus Schäfers
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hartmut Lerche
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Wolfgang Brandau
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Samuel Samnick
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Hansdetlef Wassmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Otmar Schober
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Woesler, B., Kuwert, T., Morgenroth, C. et al. Non-invasive grading of primary brain tumours: Results of a comparative study between SPET with123I-α-methyl tyrosine and PET with18F-deoxyglucose. Eur J Nucl Med 24, 428–434 (1997). https://doi.org/10.1007/BF00881816

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00881816

Key words

Search

Navigation